CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MHRA (UK)
High ImpactOriginal article

National Patient Safety Alert: ResMed Astral 100 and 150 Ventilators: Potential for Patient Harm due to Unexpected Interruption of Ventilation Therapy (NatPSA/2026/004/MHRA)

RegulatoryAstral 100Astral 150Negative
AI Analysis

Summary

ResMed issued a Field Safety Notice for Astral 100 and 150 ventilators manufactured prior to October 2024 due to a fault that can cause unexpected interruption of ventilation therapy, posing potential patient harm.

Outcome Details

Field Safety Notice issued for potential unexpected interruption of ventilation therapy in Astral 100 and 150 ventilators manufactured prior to October 2024

Importance:8/10
Sentiment:
-0.90
patient safetyfield safety noticemedical deviceventilatorMHRAproduct recall
Related Companies

Read the original article

Published by MHRA (UK) on August 17, 2026 8:30 AM

Read Original